Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter May 11, 2018

Definition of reference ranges for β-isomerized carboxy-terminal telopeptide collagen type I for children and adolescents

Veronica C.P. de Melo, Paulo R.S. Ferreira, Lucelia O. Ricardi, Marcelo C. Batista, Carolina N. França and Carlos E. dos S. Ferreira

Abstract

Background:

Bone metabolism involves many complex pathways that are disturbed by several bone diseases. The literature shows some limitations concerning pediatric reference intervals to bone markers, mainly because of the low number of patients included in the studies, the heterogeneity of methods, beyond the fact that it is time-consuming and expensive. The aim of this study was to determine reference values for β-isomerized carboxy-terminal telopeptides collagen type I (β-CTX), a marker of bone resorption, for children and adolescents.

Methods:

Blood samples from 246 patients were collected and β-CTX was measured using an electrochemiluminescence immunoassay (ECLI).

Results and conclusions:

We propose reference ranges for β-CTX concentration from the 2.5 percentile and 97.5 percentile for each age group. The reference values obtained, concerning children and adolescents, might be useful in the evaluation of diseases such as osteosarcoma and anorexia in both childhood as adolescence.


Corresponding author: Carlos E. dos S. Ferreira, PhD, Hospital Israelita Albert Einstein, Albert Einstein Avenue, 625 to 701, São Paulo, SP, Brazil, Phone: +55 1198451 9909

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Garnero P. New developments in biological markers of bone metabolism in osteoporosis. Bone 2014;66:46–55.10.1016/j.bone.2014.05.016Search in Google Scholar

2. Gayretti Aydin ZG, Bideci A, Emeksiz HC, Çelik N, Döger E, et al. Assessment of bone turnover markers and bone mineral density in normal short boys. J Pediatr Endocrinol Metab 2015;28:1321–6.10.1515/jpem-2014-0099Search in Google Scholar

3. Seibel MJ, Woitge HW. Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom 1999;2:299–321.10.1385/JCD:2:3:299Search in Google Scholar

4. Gennai I, Di Iorgi N, Reggiardo G, Gatti C, Bertelli E, et al. Age- and sex-matched reference curves for serum collagen type I C-telopeptides and bone alkaline phosphatase in children and adolescents: an alternative multivariate statistical analysis approach. Clin Biochem 2016;49:802–7.10.1016/j.clinbiochem.2016.04.005Search in Google Scholar

5. Herrmann D, Intemann T, Lauria F, Marild S, Molnár D, et al. Reference values of bone stiffness index and C-terminal telopeptide in healthy European children. Int J Obes 2014;38:S76–85.10.1038/ijo.2014.138Search in Google Scholar

6. Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006;39:561–8.10.1016/j.clinbiochem.2005.11.015Search in Google Scholar

7. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTX): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002;31:57–61.10.1016/S8756-3282(02)00791-3Search in Google Scholar

8. Hu T, Yang Q, Xu J, Zhang Z, He N, et al. Role of β-isomerized C-terminal telopeptides (β-CTX) and total procollagen type 1 amino-terminal propeptide (tP1NP) as osteosarcoma biomarkers. Int J Clin Exp Med 2015;8:890–6.Search in Google Scholar

9. Ruza E, Sierrasesúmaga L, Azcona C, Patiño-Garcia A. Bone mineral density and bone metabolism in children treated for bone sarcomas. Ped Res 2006;59:866–71.10.1203/01.pdr.0000219129.12960.c2Search in Google Scholar

10. Michou L, Orcel P. The changing countenance of Paget’s disease of bone. Joint Bone Spine 2016;83:650–5.10.1016/j.jbspin.2016.02.011Search in Google Scholar PubMed

11. Yavropoulou MP, Tomos K, Tsekmekidou X, Anastasiou O, Zebekakis P, et al. Response of biochemical markers of bone turnover to oral glucose load in diseases that affect bone metabolism. Eur J Endocrinol 2011;164:1035–41.10.1530/EJE-11-0128Search in Google Scholar PubMed

12. Olmos JM, Hernández JL, Garcia-Velasco P, Martinez J, Llorca J, et al. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 2016;27:105–13.10.1007/s00198-015-3219-6Search in Google Scholar

13. Fares JE, Choucair M, Nabulsi M, Salamoun M, Shahine CH, et al. Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodelling. Bone 2003;33:242–7.10.1016/S8756-3282(03)00160-1Search in Google Scholar

14. Yilmaz D, Ersoy B, Bilgin E, Gümüser G, Onur E, et al. Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters. J Bone Miner Metab 2005;23:476–82.10.1007/s00774-005-0631-6Search in Google Scholar PubMed

15. Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, et al. Sex- and age specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 2007;92:443–9.10.1210/jc.2006-1706Search in Google Scholar PubMed

16. Wyness SP, Roberts WL, Straseski JA. Pediatric reference intervals for four serum bone markers using two automated immunoassays. Clin Chim Acta 2013;415:169–72.10.1016/j.cca.2012.10.036Search in Google Scholar PubMed

17. Ambroszkiewicz J, Gajeswka J, Klepacka T, Chełchowska M, Laskowska-Klita T, et al. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma. Adv Med Sci 2010;55:266–72.10.2478/v10039-010-0043-2Search in Google Scholar PubMed

18. Viapiana O, Gatti D, Dalle Grave R, Todesco T, Rossini M, et al. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone 2007;40:1073–7.10.1016/j.bone.2006.11.015Search in Google Scholar PubMed

19. Swenne I, Stridsberg M. Bone metabolism markers in adolescent girls with eating disorders and weight loss: effects of growth, weight trend, developmental and menstrual status. Arch Osteoporos 2012;7:125–33.10.1007/s11657-012-0090-3Search in Google Scholar PubMed

20. Huang Y, Eapen E, Steele S, Grey V. Establishment of reference intervals for bone markers in children and adolescents. Clin Biochem 2011;44:771–8.10.1016/j.clinbiochem.2011.04.008Search in Google Scholar PubMed

Received: 2018-1-2
Accepted: 2018-4-3
Published Online: 2018-5-11
Published in Print: 2018-6-27

©2018 Walter de Gruyter GmbH, Berlin/Boston